AZD0585 Phase III Long-term Study in Japan

NCT02463071 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: AZD0585
DRUG: AZD0585 placebo

Sponsor

AstraZeneca